Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
367-05-004 ISMRM Abstract

Longitudinal Tracking of Pulvinar Iron Trajectories with QSM Suggests Early Thalamic Aging in Multiple Sclerosis

Accepted
Fahad Salman1,2, Thomas Jochmann1,3, Joseph Boccardo4, Niels P Bergsland1, Michael G Dwyer1,5, Bianca Weinstock-Guttman6, Christian Riedl7, Simon Hametner7, Robert Zivadinov1,5, Gregory Wilding4, Ferdinand Schweser 1,5
1Buffalo Neuroimaging Analysis Center, Department of Neurology at the Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, The State University of New York, Buffalo, United States of America
2Department of Biomedical Engineering, University at Buffalo, The State University of New York, Buffalo, United States of America
3Insitute of Biomedical Engineering and Informatics, Department of Computer Science and Automation, Technische Universität Ilmenau, Ilmenau, Germany
4Department of Biostatistics, University at Buffalo, The State University of New York, Buffalo, United States of America
5Center for Biomedical Imaging, Clinical and Translational Science Institute, University at Buffalo, The State University of New York, Buffalo, United States of America
6Jacobs Multiple Sclerosis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, The State University of New York, Buffalo, United States of America
7Medical University of Vienna, Vienna, Austria
Presenting Author: Ferdinand Schweser

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Cortes N, Ladret HJ, Abbas-Farishta R, Casanova C. The pulvinar as a hub of visual processing and cortical integration. Trends Neurosci. 2024;47(2):120-134. doi:10.1016/j.tins.2023.11.008 [doi]
2. Schweser F, Raffaini Duarte Martins AL, Hagemeier J, et al. Mapping of thalamic magnetic susceptibility in multiple sclerosis indicates decreasing iron with disease duration: A proposed mechanistic relationship between inflammation and oligodendrocyte vitality. NeuroImage. 2018;167:438-452. doi:10.1016/j.neuroimage.2017.10.063 [doi]
3. Salman F, Bergsland N, Dwyer MG, Weinstock-Guttman B, Zivadinov R, Schweser F. Longitudinal trajectories of magnetic susceptibility in the pulvinar provide further evidence for accelerated decline of thalamic iron in multiple sclerosis (MS). Proc Intl Soc Mag Reson Med. Published online 2020.
4. Cagol A, Ocampo-Pineda M, Lu PJ, et al. Advanced Quantitative MRI Unveils Microstructural Thalamic Changes Reflecting Disease Progression in Multiple Sclerosis. Neurol Neuroimmunol Neuroinflammation. 2024;11(6):e200299. doi:10.1212/NXI.0000000000200299 [doi]
5. Hallgren B, Sourander P. THE EFFECT OF AGE ON THE NON-HAEMIN IRON IN THE HUMAN BRAIN. J Neurochem. 1958;3(1):41-51. doi:10.1111/j.1471-4159.1958.tb12607.x [doi]
6. Azevedo CJ, Cen SY, Khadka S, et al. Thalamic atrophy in multiple sclerosis: A magnetic resonance imaging marker of neurodegeneration throughout disease. Ann Neurol. 2018;83(2):223-234. doi:10.1002/ana.25150 [doi]
7. Schweser F, Hagemeier J, Dwyer MG, et al. Decreasing brain iron in multiple sclerosis: The difference between concentration and content in iron MRI. Hum Brain Mapp. 2021;42(5):1463-1474. doi:10.1002/hbm.25306 [doi]
8. Ward RJ, Zucca FA, Duyn JH, Crichton RR, Zecca L. The role of iron in brain ageing and neurodegenerative disorders. Lancet Neurol. 2014;13(10):1045-1060. doi:10.1016/S1474-4422(14)70117-6 [doi]
9. Amin M, Ontaneda D. Thalamic Injury and Cognition in Multiple Sclerosis. Front Neurol. 2021;11:623914. doi:10.3389/fneur.2020.623914 [doi]
10. Salman F, Boccardo J, Bergsland N, et al. Consistent Intra-Subject Trajectories of Iron Accumulation in the Thalamus and Putamen Revealed by Longitudinal Change-Point Mixed Effects Analysis. Proc Intl Soc Mag Reson Med. Published online 2024.
11. Hagemeier J, Zivadinov R, Dwyer MG, et al. Changes of deep gray matter magnetic susceptibility over 2 years in multiple sclerosis and healthy control brain. NeuroImage Clin. 2018;18:1007-1016. doi:10.1016/j.nicl.2017.04.008 [doi]
12. Sun H, Wilman AH. Background field removal using spherical mean value filtering and Tikhonov regularization. Magn Reson Med. 2014;71(3):1151-1157. doi:10.1002/mrm.24765 [doi]
13. Schweser F, Sommer K, Deistung A, Reichenbach JR. Quantitative susceptibility mapping for investigating subtle susceptibility variations in the human brain. NeuroImage. 2012;62(3):2083-2100. doi:10.1016/j.neuroimage.2012.05.067 [doi]
14. Bilgic B, Costagli M, Chan KS, et al. Recommended Implementation of Quantitative Susceptibility Mapping for Clinical Research in The Brain: A Consensus of the ISMRM Electro-Magnetic Tissue Properties Study Group. ArXiv. Published online July 5, 2023:arXiv:2307.02306v1.
15. Salman F, Thomas K, Adegbemigun A, et al. Bi-parametric Joint Label Fusion A Comprehensive Segmentation Tool for Deep Gray Matter in QSM. EMTP QMR. Published online 2024.
16. Zhang Y, Wei H, Cronin MJ, He N, Yan F, Liu C. Longitudinal data for magnetic susceptibility of normative human brain development and aging over the lifespan. Data Brief. 2018;20:623-631. doi:10.1016/j.dib.2018.06.005 [doi]
17. Feng X, Deistung A, Dwyer MG, et al. An improved FSL-FIRST pipeline for subcortical gray matter segmentation to study abnormal brain anatomy using quantitative susceptibility mapping (QSM). Magn Reson Imaging. 2017;39:110-122. doi:10.1016/j.mri.2017.02.002 [doi]
18. Li X, Chen L, Kutten K, et al. Multi-atlas tool for automated segmentation of brain gray matter nuclei and quantification of their magnetic susceptibility. NeuroImage. 2019;191:337-349. doi:10.1016/j.neuroimage.2019.02.016 [doi]
19. Riedl CJ, Bormann D, Steinmaurer A, et al. Inflammation alters myeloid cell and oligodendroglial iron-handling in multiple sclerosis. Acta Neuropathol Commun. 2025;13(1):124. doi:10.1186/s40478-025-02020-0 [doi]
20. McKay KA, Manouchehrinia A, Berrigan L, Fisk JD, Olsson T, Hillert J. Long-term Cognitive Outcomes in Patients With Pediatric-Onset vs Adult-Onset Multiple Sclerosis. JAMA Neurol. 2019;76(9):1028. doi:10.1001/jamaneurol.2019.1546 [doi]
21. Paul S, Gallagher E, Liow JS, et al. Building a database for brain 18 kDa translocator protein imaged using [11 C]PBR28 in healthy subjects. J Cereb Blood Flow Metab. 2019;39(6):1138-1147. doi:10.1177/0271678X18771250 [doi]

Cite this abstract